-
-
-
-
-
-
-
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
-
-
-
-
-
-
-
Collegium Pharmaceutical (COLL) PT Lowered to $40 at Jefferies
-
-
-
-
-
-
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
-
-
-
-
-
-
-
Collegium Pharma (COLL) Acquires BioDelivery Sciences International (BDSI) For $5.60/sh
-
-
-
-
-
-
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
-
-
-
-
-
-
-
Collegium Pharmaceutical (COLL) PT Lowered to $32 at Jefferies
-
-
-
-
-
-
-
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
-
72,046 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

